Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 7.10%61.39B | 3.68%243.38B | 0.14%57.32B | 3.22%234.74B | 1.14%55.33B | 3.34%64.72B | 3.08%57.46B | 5.30%57.24B | 7.48%227.42B | 7.62%54.7B |
| Cost of revenue | 6.40%39.95B | 2.40%158.87B | -1.59%37.55B | 2.48%155.15B | -1.38%36.56B | 0.82%42.33B | 3.18%38.11B | 7.76%38.15B | 11.76%151.4B | 11.00%37.07B |
| Gross profit | 8.42%21.44B | 6.18%84.51B | 3.61%19.77B | 4.68%79.59B | 6.45%18.77B | 8.46%22.38B | 2.89%19.35B | 0.71%19.08B | -0.13%76.03B | 1.15%17.63B |
| Operating expense | 3.34%17.23B | 2.55%68.87B | 1.67%16.68B | 3.19%67.16B | 2.38%17.06B | 1.32%16.97B | 4.90%16.73B | 4.29%16.4B | 5.50%65.09B | 0.66%16.67B |
| Operating profit | 35.78%4.21B | 25.81%15.64B | 15.43%3.1B | 13.59%12.43B | 76.55%1.71B | 39.24%5.41B | -8.32%2.62B | -16.78%2.68B | -24.18%10.94B | 10.38%968M |
| Net non-operating interest income (expenses) | 430.00%33M | 107.50%3M | 0.00%-10M | 6.98%-40M | -10.00%-11M | 10.00%-9M | 9.09%-10M | 16.67%-10M | 18.87%-43M | 0.00%-10M |
| Non-operating interest income | 1,700.00%54M | 2,100.00%66M | 200.00%3M | -40.00%3M | --0 | 0.00%1M | -50.00%1M | 0.00%1M | 25.00%5M | -50.00%1M |
| Non-operating interest expense | 61.54%21M | 46.51%63M | 18.18%13M | -10.42%43M | 0.00%11M | -9.09%10M | -15.38%11M | -15.38%11M | -15.79%48M | -8.33%11M |
| Net investment income | 23.81%234M | 6.17%396M | -2.58%189M | -19.09%373M | 12.50%9M | -12.77%164M | -80.65%6M | -17.09%194M | 3.60%461M | -63.64%8M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 125.23%54M | -79.46%273M | -214M | -9.71%1.33B | 76M | -92.77%107M | 1.15B | 0 | 27.56%1.47B | 0 |
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | -46.81%-69M | -71.53%-470M | 38.96%-47M | 63.17%-274M | 151.20%85M | 30.62%-145M | 18.93%-137M | 61.50%-77M | -179.70%-744M | -154.25%-166M |
| Less:Other special charges | 58.54%65M | 71.98%442M | -45.33%41M | -62.37%257M | -157.72%-86M | -30.65%138M | -20.73%130M | -56.14%75M | 413.53%683M | 144.88%149M |
| Less:Write off | -33.33%4M | 64.71%28M | 200.00%6M | -72.13%17M | -94.12%1M | -30.00%7M | 40.00%7M | -93.10%2M | -54.14%61M | -34.62%17M |
| Other non-operating income (expenses) | -66.67%2M | -187.50%-28M | -14.29%6M | -75.76%32M | -64.18%24M | -266.67%-5M | -45.45%6M | -86.27%7M | 266.67%132M | 3,250.00%67M |
| Income before tax | 47.70%4.46B | 14.17%15.81B | 7.94%3.02B | 13.33%13.85B | 118.22%1.89B | 3.47%5.52B | 33.46%3.63B | -14.96%2.8B | -22.40%12.22B | -62.98%867M |
| Income tax | 45.41%1.38B | 8.59%4.72B | 8.60%947M | 14.38%4.34B | 124.56%631M | 3.44%1.71B | 30.97%1.13B | -12.80%872M | -21.50%3.8B | -59.51%281M |
| Net income | 48.70%3.08B | 16.74%11.09B | 7.64%2.07B | 12.87%9.5B | 115.19%1.26B | 3.48%3.81B | 34.61%2.51B | -15.90%1.93B | -22.82%8.42B | -64.46%586M |
| Net income continuous operations | 48.75%3.08B | 16.72%11.09B | 7.64%2.07B | 12.87%9.5B | 115.19%1.26B | 3.48%3.81B | 34.61%2.51B | -15.90%1.93B | -22.81%8.42B | -64.44%586M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 48.70%3.08B | 16.74%11.09B | 7.64%2.07B | 12.87%9.5B | 115.19%1.26B | 3.48%3.81B | 34.61%2.51B | -15.90%1.93B | -22.82%8.42B | -64.46%586M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 48.70%3.08B | 16.74%11.09B | 7.64%2.07B | 12.87%9.5B | 115.19%1.26B | 3.48%3.81B | 34.61%2.51B | -15.90%1.93B | -22.82%8.42B | -64.46%586M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 51.70%46.01 | 18.83%163.15 | 10.81%30.33 | 16.56%137.3 | 114.19%18.72 | 6.73%55.21 | 38.36%36 | -12.56%27.37 | -21.00%117.79 | -61.24%8.74 |
| Diluted earnings per share | 51.70%46.01 | 18.83%163.15 | 10.81%30.33 | 16.56%137.3 | 121.55%18.4526 | 6.73%55.21 | 38.36%36 | -12.56%27.37 | -21.00%117.79 | -63.06%8.3288 |
| Dividend per share | 0 | 44.44%78 | 0 | 3.85%54 | 3.85%27 | 0 | 3.85%27 | 0 | 13.04%52 | 0.00%26 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |